The round was led by Cove Fund II, a prominent California life science and technology fund. Medtech funds Wavemaker Three-Sixty Health and Device of Tomorrow Capital, as well as individual investors, also participated.
“We are very bullish about the prospects for Carlsmed,” said Mike Benvenuti, co-manager of Cove Fund II. “Carlsmed’s team has the deep industry experience and operational expertise to lead the much needed shift to personalised medicine for challenging complex spine cases and beyond.”
Mike Cordonnier, CEO and co-founder of Carlsmed, said: “This round of venture financing accelerates the clinical launch of the aprevo system. Surgeons and patients across the spectrum that have postponed treatment for debilitating spinal conditions will soon have access to an affordable and streamlined system for personalised spine surgery.”
Carlsmed has also appointed Alexander Arrow as CFO and Shariq Hussain as CIO, who will lead the startup’s digital development and operations. Carlsmed said their appointments are crucial to building the infrastructure and systems necessary to scale the company to meet clinical demand.
The startup is currently incubating at EvoNexus, a non-profit technology incubator in California.
IntuitiveX is a Seattle-based life science consulting firm. Our goal is to bring real change to real life. We see the potential in ideas and apply our resources to make them possible. Our collective expertise is our most powerful asset, and we aim to serve people with a passion for change, the drive to innovate, and the desire to make a positive impact on the world around us. By working together, IntuitiveX can deliver smarter solutions and improve the lives of people, every day. From initial concept to final commercialization, IntuitiveX has the in-house knowledge and network of resources to meet the unique needs of the most innovative life sciences companies in the world.
Find out more at https://www.intuitive-x.com
Contact: Jeffrey Roh, email@example.com